Skip to main content
Premium Trial:

Request an Annual Quote

ABI Expands Biomarker Collaboration with Stanford, U of Miami to Include TaqMan Array

NEW YORK, Jan. 10 (GenomeWeb News) - Applied Biosystems has expanded an ongoing collaboration with researchers at Stanford University and the University of Miami to further study lymphoma biomarkers, the company said today.


In the new studies, the scientists will use ABI's TaqMan Low Density Array, a microfluidic card for real-time PCR, to validate the predictive value of six gene-expression based markers associated with treatment response and survival in diffuse large B cell lymphoma, the most common form of non-Hodgkin's lymphoma.


The initial study was published last April in an article in the New England Journal of Medicine entitled "Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes." For this study, the researchers used a combination of microarrays, bioinformatics, real-time PCR, and TaqMan gene expression assays, ABI said.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.